PAUL ROSENBERG: Open Payments
NPI 1942238563 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,771 in 4 payments from 2 companies in 2025. Trend: 2023 $16,708 · 2024 $15,135 · 2025 $9,771
Consulting: $9,621Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $6,156 |
| Novo Nordisk Inc | 3 | $3,615 |
Industry payments across MD — which companies pay providers there.
